https://doi.org/10.4081/hmr.v1i8.288

Bortezomib therapy for refractory/relapsed multiple myeloma

Vol. 1 No. 8: New Drugs in Hematology, Bologna, October 9-11, 2005
Published: June 3, 2009
Abstract Views: 165
PDF: 165
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

M Cavo
support@pagepress.org
The proteasome is a multienzyme complex found in all eukaryotic cells that functions to degrade most short-lived and long-lived intracellular proteins after their conjugation to ubiquitin. Many of these proteins are involved in cell cycle regulation, and their timely degradation after polyubiquitination is essential for normal cell cycling, function and survival. Inhibition of proteasome activity results in accumulation of these proteins within the cells, with subsequent cell-cycle arrest, apoptosis and downregulation of angiogenesis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Cavo, M. (2009). Bortezomib therapy for refractory/relapsed multiple myeloma. Hematology Meeting Reports (formerly Haematologica Reports), 1(8). https://doi.org/10.4081/hmr.v1i8.288
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).